The effect of DASH diet on atherogenic indices, pro-oxidant-antioxidant balance, and liver steatosis in obese adults with non-alcoholic fatty liver disease: A double-blind controlled randomized clinical trial
Health Promotion Perspectives · 30.04.2023 · 13 (1) · 77-87
DOI: 10.34172/hpp.2023.10 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Health Promotion Perspectives, online erschienen am 30.04.2023. Verfasst von Taghi Badali und 4 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
The present clinical trial aimed to examine whether adherence to Dietary Approaches to Stop Hypertension (DASH) diet could improve lipid profile, the Pro-oxidant-antioxidant balance (PAB) as well as liver function in obese adults with non-alcoholic fatty liver disease (NAFLD).
Methods
Sixty two patients with NAFLD were equally allocated into either DASH or low-calorie diet (LCD) group for 8 weeks. The primary and secondary outcomes were determined before and after the trial.
Results
Forty patients completed the trial. Significant within group differences were found in dietary saturated fat, selenium, vitamins A and E as well as body weight and body mass index (BMI) and waist circumference (WC) after the intervention (P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
- Endocrine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Nutrition Research Center, Department of Biochemistry and Diet Therapy, Faculty of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
ORCID-Profile: Taghi Badali, Sara Arefhosseini, Helda Tutunchi, Mehrangiz Ebrahimi-Mameghani
Zitieren
APA
Badali, T., Arefhosseini, S., Rooholahzadegan, F., Tutunchi, H., & Ebrahimi-Mameghani, M. (2023). The effect of DASH diet on atherogenic indices, pro-oxidant-antioxidant balance, and liver steatosis in obese adults with non-alcoholic fatty liver disease: A double-blind controlled randomized clinical trial. Health Promotion Perspectives, 13(1), 77-87. https://doi.org/10.34172/hpp.2023.10
Vancouver
Badali T, Arefhosseini S, Rooholahzadegan F, Tutunchi H, Ebrahimi-Mameghani M. The effect of DASH diet on atherogenic indices, pro-oxidant-antioxidant balance, and liver steatosis in obese adults with non-alcoholic fatty liver disease: A double-blind controlled randomized clinical trial. Health Promotion Perspectives. 2023;13(1):77-87. doi:10.34172/hpp.2023.10
BibTeX
@article{Badali2023,
author = {Badali, Taghi and Arefhosseini, Sara and Rooholahzadegan, Farnaz and Tutunchi, Helda and Ebrahimi-Mameghani, Mehrangiz},
title = {The effect of DASH diet on atherogenic indices, pro-oxidant-antioxidant balance, and liver steatosis in obese adults with non-alcoholic fatty liver disease: A double-blind controlled randomized clinical trial},
journal = {Health Promotion Perspectives},
year = {2023},
volume = {13},
number = {1},
pages = {77--87},
doi = {10.34172/hpp.2023.10}
}
EUVIMED